Germany: Drug Spending Crack Down Could Mean Tougher Reference Pricing Measures
Executive Summary
Pricing reforms in Germany could have a ripple effect elsewhere as other countries look for inspiration on how to rein in pharmaceutical spending.
You may also be interested in...
Germany’s New Government Will Maintain Price Freeze And Slash Free Pricing Period
Big changes are in store on the drug pricing front in Germany. Further reforms could depend on who is appointed health minister.
Mexico Continues Reliance Strategy To Expand Drug Access
Mexico aims to speed up the registration of generics and biosimilars.
Belgium Aims To Drive Biologic Competition Through Tendering
New tendering rules in Belgium aim to improve competition between biosimilars and originators, for example by setting contract durations for tendering contracts and limiting the criteria for such contracts.